Your session is about to expire
← Back to Search
COVID-19 education for Motivational Interviewing
N/A
Waitlist Available
Led By Steffanie Strathdee, PhD
Research Sponsored by University of California, San Diego
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months
Awards & highlights
Study Summary
This trial is testing an intervention to increase COVID-19 testing and vaccination among people who inject drugs in San Diego County. Results will inform future efforts to reduce COVID-19 health disparities.
Who is the study for?
This trial is for individuals enrolled in La Frontera who haven't been tested for COVID-19 recently or have had certain symptoms without a positive test. They should not be fully vaccinated or only partially vaccinated with specific time frames since their last shot.Check my eligibility
What is being tested?
The LinkUP intervention aims to increase COVID-19 testing and vaccination among people who inject drugs (PWID) by providing education and motivational interviewing, assessing its potential effectiveness for broader use.See study design
What are the potential side effects?
Since the interventions involve education and motivational interviewing, there are no direct medical side effects. However, participants may experience discomfort discussing personal health behaviors.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 6 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
COVID-19 Testing
Secondary outcome measures
COVID-19 Vaccination
Trial Design
2Treatment groups
Experimental Treatment
Placebo Group
Group I: LinkUP Active interventionExperimental Treatment1 Intervention
The counselor will present basic evidence-based COVID-19 information on SARS-CoV-2 biology and epidemiology, testing and the safety and efficacy of available COVID-19 vaccines. The counselor will also address COVID-19 misinformation (e.g., that COVID is no worse than the flu), and COVID-19 disinformation (e.g., that COVID vaccines include a tracking device).
The LinkUP active intervention combines education, motivational interviewing (MI), problem-solving, and ongoing support from peer counselors. Through an open discussion with one of OnPoint's peer counselors who are trained in MI, the counselor will present evidence-based COVID-19 information. Next, the counselor will attempt to identify the participant's concerns about COVID-19 and vaccination in an attempt to tip their decisional balance.
Group II: LinkUP Control Condition (didactic intervention)Placebo Group1 Intervention
As described above, the control condition is a one-way sharing of COVID-19 information presented by an OnPoint counselor. The counselor will be instructed to answer any questions the participant may have but will not engage in motivational interviewing counseling. The same educational materials used in the LinkUP intervention module will be used for this session and it will be completed within 45 minutes.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
COVID-19 education
2022
N/A
~150
Find a Location
Who is running the clinical trial?
National Institute on Drug Abuse (NIDA)NIH
2,465 Previous Clinical Trials
2,618,483 Total Patients Enrolled
1 Trials studying Motivational Interviewing
89 Patients Enrolled for Motivational Interviewing
University of California, San DiegoLead Sponsor
1,120 Previous Clinical Trials
1,521,257 Total Patients Enrolled
Steffanie Strathdee, PhDPrincipal InvestigatorUniversity of California, San Diego
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:Research Study Groups:
This trial has the following groups:- Group 1: LinkUP Active intervention
- Group 2: LinkUP Control Condition (didactic intervention)
Awards:
This trial has 0 awards, including:Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are there any current vacancies in this clinical trial?
"According to clinicaltrials.gov, this medicinal research is not presently recruiting patients - it was initially posted on the 15th of March 2022 and last revised on June 6th 2022. However, there are 7 other trials in progress that require participants at present."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger